All4NutraNo products in the cart.
All4NutraStartseite » Drug Carrier » Page 4
Bacterial immunity to antibiotics is currently increasing as a result of inadequate drug use and the generation of antimicrobial resistance....
Osteoarthritis (OA) is a prevalent degenerative disease that has a significant impact on patients' lives. Celecoxib (CXB) is now primarily used to treat OA with...
A significant proportion of pharmaceuticals are now considered multiparticulate systems. Modified-release drug delivery formulations can be designed with engineering precision,...
The solubility of a drug is higher when it is in an amorphous form than when it is in a...
Integrated API and drug product processing enable molecules with high clinical efficacy but poor physicochemical characteristics to be commercialized by...
Powders for nasal delivery have been recognized as advantageous dosage forms over liquids due to increased stability and residence time...
A novel approach for preparing drug-containing particles (DCPs) with controlled size distribution and high drug loading was developed using melt...
Dry powder inhalation offers a well-established administration route for either local or systemic drug delivery. Lactose-based powder blends still build...
The present study aims to develop and optimize anastrozole (ANZ)-nanostructured lipid carriers (ANZ-NLCs) for improved anticancer efficacy. In a nutshell,...
The study documents the flower-like lactose particles as potential carriers to improve Dry Powder Inhaler (DPI) efficiency. The lactose particles...
Copyright: PharmaExcipients AG